MapLight Therapeutics, Inc.
MPLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $64 | $33 | $50 | $38 |
| Short-Term Investments | $163 | $27 | $42 | $71 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $18 | $13 | $6 | $6 |
| Total Curr. Assets | $245 | $73 | $98 | $115 |
| Property Plant & Equip (Net) | $7 | $7 | $7 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $3 | $11 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $4 | $3 | $3 |
| Total NC Assets | $12 | $11 | $13 | $22 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $257 | $84 | $112 | $137 |
| Liabilities | – | – | – | – |
| Payables | $2 | $0 | $0 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $2 | $3 | $3 |
| Other Curr. Liab. | $14 | $12 | $9 | $9 |
| Total Curr. Liab. | $19 | $15 | $13 | $16 |
| LT Debt | $5 | $5 | $6 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $508 | $0 | $0 | $309 |
| Total NC Liab. | $513 | $5 | $6 | $315 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6 | $5 | $6 | $7 |
| Total Liabilities | $531 | $20 | $19 | $331 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $309 | $309 | $309 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$281 | -$252 | -$222 | -$199 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $7 | $6 | $6 | $6 |
| Total Equity | -$274 | $64 | $93 | -$194 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $257 | $84 | $112 | $137 |
| Net Debt | -$58 | -$27 | -$44 | -$31 |